This week in dental tourism #6: the Osstem counterfeit alert nobody covered

On 18 December 2025, Osstem Hong Kong published a safety alert stating that counterfeit Osstem implant fixtures were circulating in the market, repackaged to look authentic [1]. The alert reported test findings: 9 of 12 sampled fakes failed essential safety standards, and material hardness measured a 42% decrease relative to genuine product, which the alert tied to raised fracture risk [1]. Osstem is one of the dominant mid-market implant brands in the two highest-volume Asian dental tourism destinations this column covers, Vietnam and Thailand. The alert received almost no coverage. That combination is this week’s lead: a structural-safety finding about a high-volume fixture, in the markets where that fixture is most used, that nobody picked up.

Before the item, the source caveat, stated up front because the brand voice of this publication requires it. The alert is published by Osstem Hong Kong, the manufacturer’s regional entity. The manufacturer is an interested party: a counterfeit alert protects the genuine brand’s market and is exactly the kind of statement a manufacturer has a commercial reason to make. I am not treating the alert’s specific test numbers as independently verified, because I cannot independently verify them; I am treating them as the manufacturer’s reported findings, and I am telling you that is what they are. The clinical reasoning that follows about what a 42%-softer fixture would mean under load is mine, and it does not depend on the exact percentage being right. It depends only on a counterfeit fixture being materially softer than spec, which is the general and well-documented hazard of counterfeit medical hardware [2] [7].

Item 1: what a 42%-softer fixture means under occlusal load

The number that should stop a clinician is not “9 of 12 failed.” It is “42% lower hardness” [1]. Here is why, in clinical terms.

A dental implant fixture is a screw that lives in bone and carries the force of chewing for, in the successful case, decades [3]. Genuine fixtures from the established manufacturers are made to a defined titanium-alloy specification with a defined hardness, because hardness is one of the material properties that resists deformation and fatigue under repeated load [5] [6]. The occlusal forces a posterior implant carries are not gentle and they are not occasional. They are repeated thousands of times a day, every day, for the life of the restoration [4]. A fixture is engineered to survive that load profile across that timescale.

Drop the material hardness by a large margin and you change the fatigue behaviour of the part. A softer titanium component deforms more readily, accumulates microdamage faster under cyclic load, and reaches the threshold of mechanical failure sooner [5] [6]. The failure modes that matter clinically are screw loosening, abutment-screw fracture, and fixture fracture. Fixture fracture is the one that ends the implant, because a fractured fixture in integrated bone is among the hardest complications in implant dentistry to manage. You are not retightening a screw. You are explaining to a patient why the implant they paid for, that osseointegrated correctly, has snapped at the bone level under normal function and now requires surgical removal and a bone-healing interval before anything can be attempted again.

I do not need the 42% figure to be precisely accurate to make the clinical point. I need only the direction: a counterfeit fixture that is materially softer than the genuine specification is a fixture at elevated risk of mechanical failure under exactly the loading it exists to withstand. The patient who received it cannot feel the difference at placement. The radiograph at delivery looks the same. The integration proceeds. The failure, if it comes, comes later, under load, after the marketing promise has been kept and the warranty window has often closed. That delayed-failure profile is the same structural problem this column keeps returning to in issue 5 on the immediate-load question: the procedure can look complete and successful at the point of sale while carrying a risk that only expresses itself years downstream.

Item 2: why Vietnam and Thailand are the exposed markets

Osstem is a South Korean manufacturer and one of the most widely placed mid-market implant systems in Asia. In the Vietnamese and Thai dental tourism markets, the markets this publication covers most densely, from the Nhân Tâm Dental Ho Chi Minh City review and the Elite Dental Ho Chi Minh City review to the Bangkok Hospital Dental Center review, Osstem and its mid-market peers occupy the price tier that makes the cost arithmetic of dental tourism work. The premium-brand fixtures (the ones at the top of the implant cost-by-country reference) carry premium prices. The mid-market brands are how a full-arch case reaches the headline figure that draws the patient across a border.

That price-tier position is exactly what makes a counterfeit alert about this brand consequential. A counterfeiter targets the high-volume, mid-price product, because that is where the unit economics of faking are best [7]. The genuine mid-market fixture is affordable enough to be everywhere and expensive enough to be worth copying. The patient choosing a mid-market-brand implant in Ho Chi Minh City or Bangkok in 2026 is choosing from the exact category the alert says is being counterfeited and repackaged to look authentic [1]. This is not a reason to avoid the brand. It is a reason to verify the specific fixture, which is item 4.

Item 3: brand name as a credential, and its limits

There is a marketing move, common in the tourism-facing segment, of listing the implant brand as the reassurance. “We use Osstem.” “We use Straumann.” The brand name is offered as the proof of quality, the way “German implants” gets offered, the category error this publication took apart in the materials and crown-quality treatment review.

The counterfeit alert is the sharpest possible illustration of the limit of brand-name-as-credential. If counterfeit fixtures are repackaged to look authentic [1], then the brand name on the packaging is precisely the thing that has been copied. The credential a patient is being offered, “it’s a genuine X,” is the credential the counterfeit is designed to defeat. A brand name verifies the manufacturer’s intended product only when the supply chain that delivered it is itself verified. The name on the box is not the verification. The traceable, authenticated supply chain from manufacturer to operatory is the verification, and that is a different and harder thing to demonstrate than a logo.

This does not mean brand is irrelevant. A genuine, traceable mid-market fixture from an established manufacturer is a defensible clinical choice at its price point. It means the brand name, on its own, does no work against the specific hazard the alert describes, because the hazard is a fake wearing the brand name.

Item 4: what a patient can actually verify

This is where the column has to be useful rather than alarming. A patient cannot test the hardness of their own fixture, and a patient should not try to evaluate a counterfeit-detection claim from the manufacturer that issued the alert. What a patient can do is shift the question from “is the brand good” to “is this specific fixture traceable,” which is the question the alert actually raises.

Before treatment, ask the clinic, in writing, for the implant system, the fixture reference, and the authorised-distributor channel the clinic buys through. Osstem’s own alert advises purchasing exclusively through authorised representatives [1]; a clinic that can name its authorised-distributor relationship is a clinic answering the question the alert poses. After treatment, ask for the implant passport or patient card: the established manufacturers supply a per-fixture record with the system, the reference, and frequently a lot or serial identifier that goes into the patient’s record and travels home with them. A clinic that places a genuine fixture has this document as a matter of routine. A clinic that cannot produce it is a clinic where the supply-chain question has no documented answer. That is not proof of a counterfeit, but it is the absence of the proof of authenticity that the alert makes newly worth having.

The bounded, named-hardware, documented quote is the same pattern this publication has identified as the strongest single predictor of a defensible plan, in the patient-who-got-it-right reflection and in the four-filter framework of when to go overseas for dental treatment. The Osstem alert adds one line to that pattern: the named hardware should come with the traceable provenance that makes the name mean what it says.

Why nobody covered it, and why that is the column’s job

A manufacturer safety notice about counterfeit fixtures, posted to a regional social channel a week before Christmas, is not a story the mainstream press is built to catch. It has no named victim, no court date, no press release from a regulator. It is a technical notice from an interested party about a structural-safety problem in a product most people have never heard of, in markets most source-country readers will never visit. It is, in other words, exactly the kind of item that falls through every coverage net except a column whose entire job is to read the dental tourism supply chain for the signals that do not make the news.

I cannot verify the manufacturer’s test numbers, and I have said so three times because it is the honest frame. What I can say is that a counterfeit-fixture problem in the dominant mid-market brand, in the two highest-volume Asian destinations, is a supply-chain risk worth a patient’s attention regardless of whether the precise figure is 42% or 30% or 55%. The direction is the story. The fixture you cannot trace is the fixture you cannot trust, and the brand name on the box is the part the counterfeit copies first.

Prior issues: issue 1 sets the column’s framing and sourcing posture. Issue 2, issue 3, and issue 4 cover the domestic-cost and insurance arc. Issue 5 covers the immediate-load question, the closest companion to this week’s delayed-failure theme. For the cost arithmetic that puts mid-market fixtures at the centre of the tourism market, see the implant cost-by-country reference. For the brand-as-credential category error, see the materials and crown-quality treatment review. For the verification habit that answers the supply-chain question, see the patient who got it right and when to go overseas for dental treatment.